Contacera

Authorised

This medicine is authorised for use in the European Union

meloxicam

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Contacera : EPAR - Summary for the public

Reference Number: EMA/655650/2012

Product information

Contacera : EPAR - Product Information

Contacera : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Contacera
• Active substance:
  meloxicam
• International non-proprietary name (INN) or common name:
  meloxicam

Pharmacotherapeutic group

Anti-inflammatory and anti-rheumatic products, non-steroids

Authorisation details

• EMA product number:
  EMEA/V/C/002612
• Generic:

  This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Assessment history

Changes since initial authorisation of medicine

Contacera : EPAR - Procedural steps taken and scientific information after authorisation

Contacera-V-C-2612-X-02 : EPAR - Assessment Report - Extension

Adopted Reference Number: EMA/18083/2014

CVMP post-authorisation summary of positive opinion for Contacera

Adopted Reference Number: EMA/CVMP/694589/2013

Initial marketing authorisation documents

Contacera : EPAR - Public assessment report

Reference Number: EMA/CVMP/716044/2012

CVMP summary of positive opinion for Contacera

Adopted Reference Number: EMA/CVMP/486534/2012